Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response

被引：0
|
作者：
Kerryn Elliott
Jonas Nilsson
Jimmy Van den Eynden
机构：
[1] Sahlgrenska Academy at University of Gothenburg,Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine
[2] University of Gothenburg and Sahlgrenska University Hospital,Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences
[3] University of Western Australia,Harry Perkins Institute of Medical Research
[4] Ghent University,Department of Human Structure and Repair, Anatomy and Embryology Unit
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Mechanism of action of a novel agonist TNFR2 antibody that induces co-stimulation of T cells and promotes robust anti-tumor immunity
    Fulton, Ross B.
    Camblin, Adam
    Sampson, James F.
    Richards, Jennifer
    Wong, Christina
    Koshkaryev, Alexander
    Luus, Lia
    Jiao, Yang
    Xu, Lihui
    Paragas, Violette
    Razlog, Maja
    Muda, Marco
    Tam, Eric M.
    Drummond, Daryl C.
    Raue, Andreas
    CANCER RESEARCH, 2019, 79 (13)
  • [42] Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
    Elizabeth S. Gabitzsch
    Younong Xu
    Joseph P. Balint
    Zachary C. Hartman
    H. Kim Lyerly
    Frank R. Jones
    Cancer Immunology, Immunotherapy, 2010, 59 : 1131 - 1135
  • [43] Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
    Gabitzsch, Elizabeth S.
    Xu, Younong
    Balint, Joseph P., Jr.
    Hartman, Zachary C.
    Lyerly, H. Kim
    Jones, Frank R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (07) : 1131 - 1135
  • [44] TARGETING ALTERNATIVE SPLICING VARIANTS TO STIMULATE ANTI-TUMOR IMMUNITY IN A NOVEL SYNGENEIC MOUSE MODEL OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT
    Wang, Anthony
    Owens, Geoffrey
    Pan, Yang
    Kim, Wi-Jin
    Sun, Matthew
    Peeters, Sophie
    Treger, Janet
    Lee, Alexander
    Armellini, Amber
    Na, Brian
    Everson, Richard
    Daniels, David
    Nathanson, David
    Liau, Linda
    Prins, Robert
    Xing, Yi
    NEURO-ONCOLOGY, 2024, 26
  • [45] Long non-coding RNA NORAD interaction with miR-346 impacts DNA damage response and anti-tumor immunity in prostate cancer.
    Fletcher, Claire
    Deng, Lin
    Orafidiya, Folake
    Yuan, Wei
    Figueiredo, Ines
    Gurel, Bora
    Leach, Damien
    Issa, Fadi
    Neeb, Antje
    Bogdan, Denisa
    Dobbs, Felix
    Philippou, Yiannis
    Murphy, Emma A.
    Zhao, Shuang G.
    Hester, Joanna
    Bryant, Richard J.
    Reed, Simon H.
    Knudsen, Karen E.
    Mills, Ian G.
    de Bono, Johann
    Bevan, Charlotte L.
    CANCER RESEARCH, 2021, 81 (13)
  • [46] TARGETING ALTERNATIVE SPLICING VARIANTS TO STIMULATE ANTI-TUMOR IMMUNITY IN A NOVEL SYNGENEIC MOUSE MODEL OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34MUTANT
    Owens, Geoffrey
    Pan, Yang
    Treger, Janet
    Contreras, Erick
    Soto, Horacio
    Armellini, Amber
    Na, Brian
    Liau, Linda
    Prins, Robert
    Xing, Yi
    Wang, Anthony
    NEURO-ONCOLOGY, 2023, 25
  • [47] Activating mucosal-associated invariant T cells (MAITs) induces a broad anti-tumor response and offers a novel target for cancer immunotherapy.
    Ruf, Benjamin
    Wabitsch, Simon
    Ma, Chi
    Diggs, Laurence P.
    Heinrich, Bernd
    Catania, Vanessa V.
    Subramanyam, Varun
    Cui, Linda
    Sakai, Shunsuke
    Oh, Sangmi
    Barry, Clifton E.
    Barber, Daniel L.
    Greten, Tim F.
    CANCER RESEARCH, 2021, 81 (13)
  • [48] Loss of intra-tumoral RIG-I immune signaling is a potential microbiome-mediated mechanism underlying poor anti-tumor immunity and immunotherapy resistance in mucosal melanoma
    MacBeth, Morgan
    Tobin, Richard
    Van Gulick, Robert
    McCarter, Martin D.
    Robinson, William A.
    Couts, Kasey L.
    CANCER RESEARCH, 2021, 81 (05)
  • [49] Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules
    Alaaeldin, Eman
    Abu Lila, Amr S.
    Ando, Hidenori
    Fukushima, Masakazu
    Huang, Cheng-Long
    Wada, Hiromi
    Sarhan, Hatem A.
    Khaled, Khaled A.
    Ishida, Tatsuhiro
    JOURNAL OF CONTROLLED RELEASE, 2017, 255 : 210 - 217
  • [50] DNA repair inhibition via targeting ATR activates cGAS/STING signaling, promotes anti-tumor immunity, and is a synthetic lethal strategy to augment immunotherapy response in preclinical models and clinical samples of small cell lung cancer
    Sen, Triparna
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
12345